Press Coverage

77% of Patients Ignore FDA Safety Recommendations for Ambien

Article on study published in JAMA Internal Medicine that was co-authored by ISMP's Senior Scientist summarizes safety concerns regarding Ambien use, including combining two or more drugs that depress the central nervous system, sustained instead of short-term use, and a higher than recommended dose or starting dose for women and older patients.

For the full text of the article, visit Healio online.

More News